Cargando…

Development and Validation of HPLC Method for the Determination of Pregabalin in Capsules

A simple, precise, specific, and accurate reverse phase HPLC method has been developed for the determination of pregabalin in capsule dosage form. The chromatography was set on Hypersil BDS, C8, 150×4.6 mm, 5 μm column using photodiode array detector. The mobile phase consisting of phosphate buffer...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasawar, G. B., Farooqui, M. N.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3013579/
https://www.ncbi.nlm.nih.gov/pubmed/21218069
http://dx.doi.org/10.4103/0250-474X.73935
_version_ 1782195286549987328
author Kasawar, G. B.
Farooqui, M. N.
author_facet Kasawar, G. B.
Farooqui, M. N.
author_sort Kasawar, G. B.
collection PubMed
description A simple, precise, specific, and accurate reverse phase HPLC method has been developed for the determination of pregabalin in capsule dosage form. The chromatography was set on Hypersil BDS, C8, 150×4.6 mm, 5 μm column using photodiode array detector. The mobile phase consisting of phosphate buffer pH 6.9 and acetonitrile in the ratio of 95:05 with flow rate of 1 ml/min. The method was validated according to ICH guidelines with respect to specificity, linearity, accuracy, precision and robustness. Lower limit of quantification is 0.6 mg/l. The pregabalin sample solution was found to be stable at room temperature for about 26 h.
format Text
id pubmed-3013579
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-30135792011-01-07 Development and Validation of HPLC Method for the Determination of Pregabalin in Capsules Kasawar, G. B. Farooqui, M. N. Indian J Pharm Sci Short Communications A simple, precise, specific, and accurate reverse phase HPLC method has been developed for the determination of pregabalin in capsule dosage form. The chromatography was set on Hypersil BDS, C8, 150×4.6 mm, 5 μm column using photodiode array detector. The mobile phase consisting of phosphate buffer pH 6.9 and acetonitrile in the ratio of 95:05 with flow rate of 1 ml/min. The method was validated according to ICH guidelines with respect to specificity, linearity, accuracy, precision and robustness. Lower limit of quantification is 0.6 mg/l. The pregabalin sample solution was found to be stable at room temperature for about 26 h. Medknow Publications 2010 /pmc/articles/PMC3013579/ /pubmed/21218069 http://dx.doi.org/10.4103/0250-474X.73935 Text en © Indian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communications
Kasawar, G. B.
Farooqui, M. N.
Development and Validation of HPLC Method for the Determination of Pregabalin in Capsules
title Development and Validation of HPLC Method for the Determination of Pregabalin in Capsules
title_full Development and Validation of HPLC Method for the Determination of Pregabalin in Capsules
title_fullStr Development and Validation of HPLC Method for the Determination of Pregabalin in Capsules
title_full_unstemmed Development and Validation of HPLC Method for the Determination of Pregabalin in Capsules
title_short Development and Validation of HPLC Method for the Determination of Pregabalin in Capsules
title_sort development and validation of hplc method for the determination of pregabalin in capsules
topic Short Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3013579/
https://www.ncbi.nlm.nih.gov/pubmed/21218069
http://dx.doi.org/10.4103/0250-474X.73935
work_keys_str_mv AT kasawargb developmentandvalidationofhplcmethodforthedeterminationofpregabalinincapsules
AT farooquimn developmentandvalidationofhplcmethodforthedeterminationofpregabalinincapsules